Biomedical Engineering Reference
In-Depth Information
22. E. Allémann, J.-C. Leroux, R. Gurny, E. Doelker, in vitro extended-release properties of drug-loaded poly
(dl-lactic acid) nanoparticles produced by a salting-out procedure, Pharmaceutical Research , 10, 1993,
1732-1737.
23. M. de Matos, A. Piedade, C. Alvarez-Lorenzo, A. Concheiro, M. Braga, H. de Sousa, SCF-assisted pro-
cessing of dexamethasone-loaded poly (ε-caprolactone)/MCM-41 materials for biomedical applications,
in: Bioengineering (ENBENG) , 2012 IEEE 2nd Portuguese Meeting in, IEEE, 2012, pp. 1-4.
24. A.S. Mayo, B.K. Ambati, U.B. Kompella, Gene delivery nanoparticles fabricated by supercritical fluid
extraction of emulsions, International Journal of Pharmaceutics , 387, 2010, 278-285.
25. A. Sane, J. Limtrakul, Formation of retinyl palmitate-loaded poly (l-lactide) nanoparticles using rapid
expansion of supercritical solutions into liquid solvents (RESOLV), The Journal of Supercritical Fluids ,
51, 2009, 230-237.
26. A. Kumar, K. Sawant, Encapsulation of exemestane in polycaprolactone nanoparticles: Optimization,
characterization, and release kinetics, Cancer Nanotechnology , 4, 2013, 57-71.
27. T. Tencomnao, K. Klangthong, N. Pimpha, S. Chaleawlert-umpon, S. Saesoo, N. Woramongkolchai,
N. Saengkrit, Acceleration of gene transfection efficiency in neuroblastoma cells through polyethyl-
eneimine/poly(methyl methacrylate) core-shell magnetic nanoparticles, International Journal of Nano-
medicine , 7, 2012, 2783.
28. A.A. Date, M.D. Joshi, V.B. Patravale, Parasitic diseases: Liposomes and polymeric nanoparticles versus
lipid nanoparticles, Advanced Drug Delivery Reviews , 59, 2007, 505-521.
29. Y. Li, L. Dong, A. Jia, X. Chang, H. Xue, Preparation and characterization of solid lipid nanoparticles loaded
traditional chinese medicine, International Journal of Biological Macromolecules , 38, 2006, 296-299.
30. R.H. Muller, C.M. Keck, Challenges and solutions for the delivery of biotech drugs—A review of drug
nanocrystal technology and lipid nanoparticles, Journal of Biotechnology , 113, 2004, 151-170.
31. Q.-B. Han, M.-L. Li, S.-H. Li, Y.-K. Mou, Z.-W. Lin, H.-D. Sun, Ent-kaurane diterpenoids from Isodon
rubescens var. lushanensis , Chemical and Pharmaceutical Bulletin , 51, 2003, 790-793.
32. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, K. Mäder, Investigations on the structure of
solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectros-
copy, field-flow fractionation and transmission electron microscopy, Journal of Controlled Release , 95,
2004, 217-227.
33. V. Venkateswarlu, K. Manjunath, Preparation, characterization and in vitro release kinetics of clozapine
solid lipid nanoparticles, Journal of Controlled Release , 95, 2004, 627-638.
34. S. Hatziantoniou, G. Deli, Y. Nikas, C. Demetzos, G.T. Papaioannou, Scanning electron microscopy
study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides, Micron , 38,
2007, 819-823.
35. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chen, Q. Zhang, Q. He, Z. Zhang, Solid lipid nanoparticles
for pulmonary delivery of insulin, International Journal of Pharmaceutics , 356, 2008, 333-344.
36. B. Du, Y. Yan, Y. Li, S. Wang, Z. Zhang, Preparation and passive target of 5-fluorouracil solid lipid
nanoparticles, Pharmaceutical Development and Technology , 15, 2010, 346-353.
37. C.M. Keck, R.H. Müller, Nanotoxicological classification system (NCS)—A guide for the risk-
benefit assessment of nanoparticulate drug delivery systems, European Journal of Pharmaceutics and
Biopharmaceutics , 84, 2013, 445-448.
38. J. Pardeike, A. Hommoss, R.H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical
dermal products, International Journal of Pharmaceutics , 366, 2009, 170-184.
39. R. Müller, S. Maaβen, H. Weyhers, F. Specht, J. Lucks, Cytotoxicity of magnetite-loaded polylactide,
polylactide/glycolide particles and solid lipid nanoparticles, International Journal of Pharmaceutics ,
138, 1996, 85-94.
40. P. Somasundaran, X. Fang, S. Ponnurangam, B. Li, Nanoparticles: Characteristics, mechanisms and
modulation of biotoxicity, KONA Powder and Particle Journal , 28, 2010, 38-49.
41. R.H. Müller, E.B. Souto, T. Göppert, S. Gohla, Production of biofunctionalized solid lipid nanoparticles
for site-specific drug delivery. In: Nanotechnologies for the Life Sciences , Challa S.S.R. Kumar (ed.),
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2007.
42. S. Dey, V. Bakthavatchalu, M.T. Tseng, P. Wu, R.L. Florence, E.A. Grulke, R.A. Yokel, S.K. Dhar, H.-S.
Yang, Y. Chen, Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth pro-
moting properties of alumina (Al 2 O 3 ) nanoparticles in mouse skin epithelial cells, Carcinogenesis , 29,
2008, 1920-1929.
43. M. Monthioux, B. Smith, B. Burteaux, A. Claye, J. Fischer, D. Luzzi, Sensitivity of single-wall car-
bon nanotubes to chemical processing: An electron microscopy investigation, Carbon , 39, 2001,
1251-1272.
Search WWH ::




Custom Search